AMPK activates and stabilizes the KLF10 protein via phosphorylation at Thr189, thereby repressing the expression of SREBP-1C and subsequent lipogenesis pathways and metabolic disorders. The gene discussed is SREBF1; the disease is Other metabolic disease.